EU H2020 Project "BIOTIMA (Market Opportunity Confirmation for Biomimetic Tissue Matrix Products)": description, partecipants, costs and EC-fundings

#	Pagina
attuale pagina	/open-h2020/projects/196233/index.html

BIOTIMA project word cloud

Explore the words cloud of the BIOTIMA project. It provides you a very rough idea of what is the project "BIOTIMA" about.

inhumane human customers physiologically culture deposited confirm plan scaling regenerative elaboration tools drug innovative prepare biocompatible morphology functional prototypes reflect nanoengineering animal biosynthetic piloted native tm regeneration patterned discovery clear made versatile advantages standard analyze map substrates ferentis nano preparation environments demonstrated industry surface feasibility thorough functionally techniques tissue clinically replication business biomimetic mimicking vitro free cosmetics models patent material biotima properly reduce primary optically toxicity expensive pending stable medicine employing fabrication variety market commercialization effort cells experiment lack artificial lab scientists materials predictive matrix roadmap modified bioplastic solution hydrogel versatility closely alternatives organs adopter composition cell seeded efficient tissues

Project "BIOTIMA" data sheet

The following table provides information about the project.

Coordinator	FERENTIS Organization address address: SAVANORIU 231 city: VILNIUS postcode: 2300 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Lithuania [LT]
Project website	http://www.ferentis.eu
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument) 2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-02-01 to 2015-07-31

#	participants	country	role	EC contrib. [€]
1	FERENTIS	LT (VILNIUS)	coordinator	50˙000.00

FERENTIS

LT (VILNIUS)

coordinator

50˙000.00

Project objective

A variety of in vitro human tissue models are used in the fields of testing of cosmetics products, drug discovery and regenerative medicine. Most models made from artificial materials do not properly reflect the native tissue morphology and cell composition, while those made of seeded cells/tissues of specific organs lack versatility and are expensive to use. Ferentis’ Biomimetic Tissue Matrix (BIOTIMA) project addresses the need for efficient toxicity testing/cell culture tools enabling more physiologically relevant, predictive and functional tissue mimicking models, that should become the EU standard in its effort to reduce expensive and inhumane animal testing. Ferentis scientists have developed an innovative patent-pending biosynthetic material –a bioplastic- that is cell-free, stable, biocompatible and optically clear and has demonstrated clinically to promote regeneration of cells. By employing advanced surface nanoengineering techniques, this biosynthetic hydrogel can be deposited, functionally modified and patterned on different substrates, for a variety of lab tissue experiment applications. The unique advantages of our tissue matrix include unique biomimetic properties, most closely mimicking those of the real tissue, and advanced nano-fabrication methods, allowing a cost efficient, versatile and easy to use solution. The prototypes of our TM cell culture tools have been demonstrated in relevant testing environments and now are being piloted with our early adopter customers, with a primary focus on the cosmetics industry. A thorough feasibility study and an elaboration of a business plan is needed in order to analyze the market, map and confirm commercialization alternatives and prepare the roadmap for scaling-up in preparation for Phase II, market replication.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOTIMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOTIMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.